Wuhan General Group (China), Inc. is a nutraceutical biotechnology company, which engages in the development of alternative plant-based cannabinoids and psilocybin medical research that commercializes a range of cannabidiol and mushrooms-based products under the Dr. AnnaRx, Medspresso and Handcrafted Delights brands. The firm is also engages in research and development of indications for psilocybin new therapies that will help patients who suffer from mental illness, Alzheimer's and Parkinson's. The company was founded by Xu Jie and Jeff Robinson on July 19, 1988 and is headquartered in Cape Town, South Africa.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A
Frequently Asked Questions
What is Market Cap of M2Bio Sciences Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. M2Bio Sciences Inc market cap is $0.00.
What is the 52-week high for M2Bio Sciences Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. M2Bio Sciences Inc 52 week high is $0.0245 as of April 16, 2024.
What is the 52-week low for M2Bio Sciences Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. M2Bio Sciences Inc 52 week low is $0.00 as of April 16, 2024.
What is the 50-day moving average of M2Bio Sciences Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. M2Bio Sciences Inc 50-day moving average is $0.00.